Sentiment Shows Investors Bullish On Aeterna In 2013: Here's Why [View article]
To correct you Tung, the author is right by saying it briefly traded under $1, it did so last year before company issued a R/S to bring the price back up above $1 to be in compliance with Nasdaq
Major Corporate And Institutional Insider Filings Last Week [View article]
ZLCS- MPM and the Form 4 sec filings they have been doing.....Justin stated quote " MPM selling there shares has nothing to do with Zalicus's fundamentals; they are selling off a small portion to raise capital they need for a later stage development on another biotech company" >>>>> he said basically its just bad timing and has NOTHING to do with zalicus as a whole.
Zalicus Inches Closer To A Strong Buy Bottom [View article]
I bought into ZLCS back in April based off reading Laser articles. I was very new to investing and still wet behind the ears. Well I watched it go to 3.20 and sold. Luck I would say yes! Heck I even bashed they guy. But I made money and will look to get back into ZLCS soon. I will watch today to see if it goes below >98 and will begin to add shares accordingly. STUDY STUDY STUDY. dont't trust anyone. Take advice but also it's your money so this is what the game is all about!
Add Questcor To Your Diversified High-Growth Biotech Portfolio [View article]
I am currently doing research on new bi-polar and multiple personality drugs for you to research stockdaug. I think if you wrote articles on such drugs it would be very in depth analysis since those two diseases hit so close to home with you. Good luck to all investors and be on the look out for this guy. He pumped ZLCS to 3.20 and today it opened around 1.55. take a look at his top bio techs, ZLCS and BPAX. he slammed ZLCS and now bpax. This guy is a piece of work. he is stockdaug on yahoo.
Zalicus: A Potential Target for Pfizer [View article]
I am not doubting laser's information but could you right some about your other top picks? $BPAX and $AIS both have potential to explode here soon. would like to hear about those too
Sentiment Shows Investors Bullish On Aeterna In 2013: Here's Why [View article]
Major Corporate And Institutional Insider Filings Last Week [View article]
Zalicus Inches Closer To A Strong Buy Bottom [View article]
Strategy For A Recessionary Portfolio [View article]
Add Questcor To Your Diversified High-Growth Biotech Portfolio [View article]
Zalicus: A Potential Target for Pfizer [View article]